Breast tumor kinase (Brk/PTK6) is induced by HIF, glucocorticoid receptor, and PELP1-mediated stress signaling in triple-negative breast cancer

Tarah M. Regan Anderson, Shi Hong Ma, Ganesh V. Raj, John A. Cidlowski, Taylor M. Helle, Todd P. Knutson, Raisa I. Krutilina, Tiffany N. Seagroves, Carol A. Lange

Research output: Contribution to journalArticlepeer-review

38 Scopus citations


Cancer cells use stress response pathways to sustain their pathogenic behavior. In breast cancer, stress response-associated phenotypes are mediated by the breast tumor kinase, Brk (PTK6), via the hypoxia-inducible factors HIF-1a and HIF-2a. Given that glucocorticoid receptor (GR) is highly expressed in triple-negative breast cancer (TNBC), we investigated cross-talk between stress hormone-driven GR signaling and HIF-regulated physiologic stress. Primary TNBC tumor explants or cell lines treated with the GR ligand dexamethasone exhibited robust induction of Brk mRNA and protein that was HIF1/2-dependent. HIF and GR coassembled on the BRK promoter in response to either hypoxia or dexamethasone, indicating that Brk is a direct GR/HIF target. Notably, HIF-2a, not HIF-1a, expression was induced by GR signaling, and the important steroid receptor coactivator PELP1 was also found to be induced in a HIF-dependent manner. Mechanistic investigations showed how PELP1 interacted with GR to activate Brk expression and demonstrated that physiologic cell stress, including hypoxia, promoted phosphorylation of GR serine 134, initiating a feed-forward signaling loop that contributed significantly to Brk upregulation. Collectively, our findings linked cellular stress (HIF) and stress hormone (cortisol) signaling in TNBC, identifying the phospho-GR/HIF/PELP1 complex as a potential therapeutic target to limit Brk-driven progression and metastasis in TNBC patients.

Original languageEnglish (US)
Pages (from-to)1653-1663
Number of pages11
JournalCancer Research
Issue number6
StatePublished - Mar 15 2016

Bibliographical note

Funding Information:
Grant Support This work was supported by the Tickle Family Land Grant Endowed Chair in Breast Cancer Research (held by C.A. Lange) and the Mary Kay Ash Breast Cancer Foundation (C.A. Lange) and by an NIH/NCI F31 predoctoral fellowship (CA195877-01 to T.M. Regan Anderson), an NIH/NCI T32 training grant fellowship (CA009138 to T.M. Regan Anderson), and NIH/NCI 1R01 (CA138488 to T.N. Seagroves). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Publisher Copyright:
© 2016 American Association for Cancer Research.


Dive into the research topics of 'Breast tumor kinase (Brk/PTK6) is induced by HIF, glucocorticoid receptor, and PELP1-mediated stress signaling in triple-negative breast cancer'. Together they form a unique fingerprint.

Cite this